- Home
- XFOR vs UBCP Comparison
XFOR vs UBCP Comparison
Compare XFOR & UBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XFOR
- UBCP
- Stock Information
- Founded
- XFOR 2014
- UBCP 1902
- Country
- XFOR United States
- UBCP United States
- Employees
- XFOR N/A
- UBCP N/A
- Industry
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- UBCP Major Banks
- Sector
- XFOR Health Care
- UBCP Finance
- Exchange
- XFOR Nasdaq
- UBCP Nasdaq
- Market Cap
- XFOR 84.3M
- UBCP 83.8M
- IPO Year
- XFOR N/A
- UBCP N/A
- Fundamental
- Price
- XFOR $3.21
- UBCP $14.27
- Analyst Decision
- XFOR Strong Buy
- UBCP
- Analyst Count
- XFOR 3
- UBCP 0
- Target Price
- XFOR $34.17
- UBCP N/A
- AVG Volume (30 Days)
- XFOR 1.5M
- UBCP 3.6K
- Earning Date
- XFOR 11-12-2025
- UBCP 11-05-2025
- Dividend Yield
- XFOR N/A
- UBCP 6.59%
- EPS Growth
- XFOR N/A
- UBCP N/A
- EPS
- XFOR N/A
- UBCP 1.28
- Revenue
- XFOR $32,774,000.00
- UBCP $29,909,000.00
- Revenue This Year
- XFOR $1,313.84
- UBCP N/A
- Revenue Next Year
- XFOR N/A
- UBCP $5.59
- P/E Ratio
- XFOR N/A
- UBCP $10.82
- Revenue Growth
- XFOR 5721.31
- UBCP 0.94
- 52 Week Low
- XFOR $1.35
- UBCP $11.72
- 52 Week High
- XFOR $26.83
- UBCP $15.64
- Technical
- Relative Strength Index (RSI)
- XFOR 51.32
- UBCP 48.36
- Support Level
- XFOR $3.08
- UBCP $13.92
- Resistance Level
- XFOR $3.79
- UBCP $14.79
- Average True Range (ATR)
- XFOR 0.40
- UBCP 0.45
- MACD
- XFOR -0.11
- UBCP -0.06
- Stochastic Oscillator
- XFOR 16.92
- UBCP 23.81
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.